Imagion Biosystems Ltd Cash Flow-to-Debt Ratio
Imagion Biosystems Ltd cash flow-to-debt ratio. Imagion Biosystems Ltd (IBX) has a Cash Flow-to-Debt Ratio of -0.54x as of December 2025, meaning its operating cash flow of AU$-2.27 Million could theoretically repay -1% of its total liabilities (AU$4.21 Million) in one year. Check how high is Imagion Biosystems Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Imagion Biosystems Ltd (2014–2025)
Cash flow-to-debt ratio of Imagion Biosystems Ltd from 2014 to 2025. Historical debt coverage capacity for Imagion Biosystems Ltd across 12 annual periods. Also explore net asset growth rate of Imagion Biosystems Ltd to track the company's year-over-year net asset growth rate.
Imagion Biosystems Ltd Cash Flow-to-Debt Ratio by Year (2014–2025)
Imagion Biosystems Ltd cash flow-to-debt ratio by year from 2014 to 2025. Year-by-year debt coverage analysis for Imagion Biosystems Ltd. For the full cash flow conversion analysis, see Imagion Biosystems Ltd operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.96x | AU$-4.04 Million | AU$4.21 Million | ▼ -284.9% |
| 2024 | -0.25x | AU$-1.27 Million | AU$5.09 Million | ▲ +74.8% |
| 2023 | -0.99x | AU$-8.32 Million | AU$8.37 Million | ▲ +34.8% |
| 2022 | -1.52x | AU$-8.07 Million | AU$5.30 Million | ▲ +75.6% |
| 2021 | -6.26x | AU$-5.07 Million | AU$809.88K | ▼ -63.1% |
| 2020 | -3.84x | AU$-4.62 Million | AU$1.21 Million | ▼ -74.2% |
| 2019 | -2.20x | AU$-4.18 Million | AU$1.90 Million | ▲ +64.3% |
| 2018 | -6.17x | AU$-8.13 Million | AU$1.32 Million | ▲ +39.1% |
| 2017 | -10.13x | AU$-6.98 Million | AU$688.77K | ▼ -1613.3% |
| 2016 | -0.59x | AU$-267.26K | AU$451.99K | ▼ -35.1% |
| 2015 | -0.44x | AU$-4.22 Million | AU$9.65 Million | ▲ +22.4% |
| 2014 | -0.56x | AU$-2.43 Million | AU$4.31 Million | — |